FDA Expected to Authorize Pfizer and Merck Covid Pills This Week

Bloomberg2021-12-22

Two drugs would be first at-home treatments for Covid-19 U.S. has ordered 13 million courses of medicines so far The U.S. Food and Drug Administration is poised to authorize a pair of pills from ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

SSVC
2021-12-22
SSVC
Nice Appreciate your response and comments Thanks
- eslebe:
  Pfizer "UltraBOOST" shot!
CSK88
2021-12-22
CSK88
Good to hear
PengsieX
2021-12-22
PengsieX
Jabs, pills... What's next

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1113826245?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-22 06:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113826245","market":"us","top_or_hot":-1,"title":"FDA Expected to Authorize Pfizer and Merck Covid Pills This Week","media":"Bloomberg","content":"<div>\n<p>Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medicines so far\n\nThe U.S. Food and Drug Administration is poised to authorize a pair of pills from ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week\">网页链接</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Expected to Authorize Pfizer and Merck Covid Pills This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Expected to Authorize Pfizer and Merck Covid Pills This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 06:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medicines so far\n\nThe U.S. Food and Drug Administration is poised to authorize a pair of pills from ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BNTX","symbol_name":"BioNTech SE","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week","article_id":"1113826245","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113826245","pubTimestamp":1640127256,"columns":[],"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medi","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BNTX":"BioNTech SE","MRK":"默沙东","PFE":"辉瑞"},"translate_title":"美国食品和药物管理局预计将于本周授权辉瑞和默克Covid药丸","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":0.9,"MRK":0.9,"PFE":0.9},"content_text":"Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medicines so far\n\nThe U.S. Food and Drug Administration is poised to authorize a pair of pills from Pfizer Inc. and Merck & Co. to treat Covid-19 as soon as this week, according to people familiar with the matter -- a milestone in the fight against the pandemic that will soon expand therapies for the ill.\nAn announcement may come as early as Wednesday, according to three of the people. They asked not to be identified ahead of the authorization and cautioned that the plan could change.\nPfizer’s pill, Paxlovid, and Merck’s molnupiravir are intended for higher-risk people who test positive for the coronavirus. The treatments, in which patients take a series of pills at home over several days, could ease the burden on stretched hospitals with infections poised to soar through the winter in the U.S.\nThe FDA declined to comment.\n“It’s the biggest thing to happen in the pandemic after vaccines,” said Eric Topol, director of the Scripps Research Translational Institute. The timing of the announcement, so late in the year, is unusual for the FDA and reflects the urgency behind the medicines, he added.\nThe FDA authorizations may come with limitations on who should get which drugs., one of the people familiar with the matter said. A Food and Drug Administration advisory committee narrowly recommended the Merck pill last month, with some members of the panel citing safety concerns including for pregnant women.\nPfizer closed at $58.95 a share in New York, down about 3.4%, while Merck closed at $75.54, down about 1.1%.\nWhite House Press Secretary Jen Psaki said she wouldn’t get ahead of any FDA decision.\n“But certainly, having antivirals available is another component that will help us fight the virus, address the pandemic, help people return to a version of normal and we will be prepared like Boy Scouts and Girl Scouts to ensure we are making these antivirals available to the public,” she said Tuesday.\nPresident Joe Biden, speaking at the White House on Tuesday about the omicron variant, said the current spike in cases is not like previous surges because of the availability of medical supplies and vaccines. He warned of increasing breakthrough cases in vaccinated people but assured Americans that almost of all of them would be mild or entirely asymptomatic.\n“No, this is not March of 2020,” he said.\nThe U.S. government has ordered 10 million courses of the Pfizer pill and about 3 million courses of Merck’s, which isn’t as effective, clinical studies indicate, and may carry risks. However, the pills are likely to not be immediately available in widespread supply.\nIn a clinical trial, Pfizer’s pill showed an 89% reduction in hospitalization for patients who received the medicine within three days of developing symptoms, compared to patients who got a placebo. None of the patients treated with the drug died.\nAuthorization for Pfizer’s pill would represent a vote of confidence in the medicine from regulators, as FDA advisers have not been asked to consider the drug’s clinical evidence.\nMerck developed molnupiravir with partner Ridgeback Biotherapeutics LP.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":691316198,"gmtCreate":1640136126530,"gmtModify":1640136129075,"author":{"id":"3574906731000207","authorId":"3574906731000207","name":"SSVC","avatar":"https://static.tigerbbs.com/545a5ea462ff4ac7cc100bd3d8d97f72","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3574906731000207","idStr":"3574906731000207"},"htmlText":"Nice Appreciate your response and comments Thanks&nbsp;","listText":"Nice Appreciate your response and comments Thanks&nbsp;","text":"Nice Appreciate your response and comments Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691316198","repostId":1113826245,"repostType":4,"repost":{"id":"1113826245","kind":"news","pubTimestamp":1640127256,"share":"https://www.laohu8.com/m/news/1113826245?lang=&edition=full","pubTime":"2021-12-22 06:54","market":"us","language":"en","title":"FDA Expected to Authorize Pfizer and Merck Covid Pills This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1113826245","media":"Bloomberg","summary":"Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medi","content":"<ul>\n <li>Two drugs would be first at-home treatments for Covid-19</li>\n <li>U.S. has ordered 13 million courses of medicines so far</li>\n</ul>\n<p>The U.S. Food and Drug Administration is poised to authorize a pair of pills from&nbsp;Pfizer Inc.&nbsp;and&nbsp;Merck &amp; Co.&nbsp;to treat Covid-19 as soon as this week, according to people familiar with the matter -- a milestone in the fight against the pandemic that will soon expand therapies for the ill.</p>\n<p>An announcement may come as early as Wednesday, according to three of the people. They asked not to be identified ahead of the authorization and cautioned that the plan could change.</p>\n<p>Pfizer’s pill, Paxlovid, and Merck’s molnupiravir are intended for higher-risk people who test positive for the coronavirus. The treatments, in which patients take a series of pills at home over several days, could ease the burden on stretched hospitals with infections poised to soar through the winter in the U.S.</p>\n<p>The FDA declined to comment.</p>\n<p>“It’s the biggest thing to happen in the pandemic after vaccines,” said Eric Topol, director of the Scripps Research Translational Institute. The timing of the announcement, so late in the year, is unusual for the FDA and reflects the urgency behind the medicines, he added.</p>\n<p>The FDA authorizations may come with limitations on who should get which drugs., one of the people familiar with the matter said. A Food and Drug Administration advisory committee narrowly recommended the Merck pill last month, with some members of the panel citing safety concerns including for pregnant women.</p>\n<p>Pfizer closed at $58.95 a share in New York, down about 3.4%, while Merck closed at $75.54, down about 1.1%.</p>\n<p>White House Press Secretary Jen Psaki said she wouldn’t get ahead of any FDA decision.</p>\n<p>“But certainly, having antivirals available is another component that will help us fight the virus, address the pandemic, help people return to a version of normal and we will be prepared like Boy Scouts and Girl Scouts to ensure we are making these antivirals available to the public,” she said Tuesday.</p>\n<p>President Joe Biden, speaking at the White House on Tuesday about the omicron variant, said the current spike in cases is not like previous surges because of the availability of medical supplies and vaccines. He warned of increasing breakthrough cases in vaccinated people but assured Americans that almost of all of them would be mild or entirely asymptomatic.</p>\n<p>“No, this is not March of 2020,” he said.</p>\n<p>The U.S. government has ordered 10 million courses of the Pfizer pill and about 3 million courses of Merck’s, which isn’t as effective, clinical studies indicate, and may carry risks. However, the pills are likely to not be immediately available in widespread supply.</p>\n<p>In a clinical trial, Pfizer’s pill showed an 89% reduction in hospitalization for patients who received the medicine within three days of developing symptoms, compared to patients who got a placebo. None of the patients treated with the drug died.</p>\n<p>Authorization for Pfizer’s pill would represent a vote of confidence in the medicine from regulators, as FDA advisers have not been asked to consider the drug’s clinical evidence.</p>\n<p>Merck developed molnupiravir with partner&nbsp;Ridgeback Biotherapeutics LP.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Expected to Authorize Pfizer and Merck Covid Pills This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Expected to Authorize Pfizer and Merck Covid Pills This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 06:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medicines so far\n\nThe U.S. Food and Drug Administration is poised to authorize a pair of pills from ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113826245","content_text":"Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medicines so far\n\nThe U.S. Food and Drug Administration is poised to authorize a pair of pills from Pfizer Inc. and Merck & Co. to treat Covid-19 as soon as this week, according to people familiar with the matter -- a milestone in the fight against the pandemic that will soon expand therapies for the ill.\nAn announcement may come as early as Wednesday, according to three of the people. They asked not to be identified ahead of the authorization and cautioned that the plan could change.\nPfizer’s pill, Paxlovid, and Merck’s molnupiravir are intended for higher-risk people who test positive for the coronavirus. The treatments, in which patients take a series of pills at home over several days, could ease the burden on stretched hospitals with infections poised to soar through the winter in the U.S.\nThe FDA declined to comment.\n“It’s the biggest thing to happen in the pandemic after vaccines,” said Eric Topol, director of the Scripps Research Translational Institute. The timing of the announcement, so late in the year, is unusual for the FDA and reflects the urgency behind the medicines, he added.\nThe FDA authorizations may come with limitations on who should get which drugs., one of the people familiar with the matter said. A Food and Drug Administration advisory committee narrowly recommended the Merck pill last month, with some members of the panel citing safety concerns including for pregnant women.\nPfizer closed at $58.95 a share in New York, down about 3.4%, while Merck closed at $75.54, down about 1.1%.\nWhite House Press Secretary Jen Psaki said she wouldn’t get ahead of any FDA decision.\n“But certainly, having antivirals available is another component that will help us fight the virus, address the pandemic, help people return to a version of normal and we will be prepared like Boy Scouts and Girl Scouts to ensure we are making these antivirals available to the public,” she said Tuesday.\nPresident Joe Biden, speaking at the White House on Tuesday about the omicron variant, said the current spike in cases is not like previous surges because of the availability of medical supplies and vaccines. He warned of increasing breakthrough cases in vaccinated people but assured Americans that almost of all of them would be mild or entirely asymptomatic.\n“No, this is not March of 2020,” he said.\nThe U.S. government has ordered 10 million courses of the Pfizer pill and about 3 million courses of Merck’s, which isn’t as effective, clinical studies indicate, and may carry risks. However, the pills are likely to not be immediately available in widespread supply.\nIn a clinical trial, Pfizer’s pill showed an 89% reduction in hospitalization for patients who received the medicine within three days of developing symptoms, compared to patients who got a placebo. None of the patients treated with the drug died.\nAuthorization for Pfizer’s pill would represent a vote of confidence in the medicine from regulators, as FDA advisers have not been asked to consider the drug’s clinical evidence.\nMerck developed molnupiravir with partner Ridgeback Biotherapeutics LP.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7072925,"gmtCreate":1640138446162,"gmtModify":1640138446226,"authorId":4100154790997510,"author":{"id":4100154790997510,"idStr":"4100154790997510","authorId":4100154790997510,"name":"eslebe","avatar":"https://static.tigerbbs.com/49b59eaa11d91f8e50747a353d6075a7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691316198,"type":1,"supId":0,"prevId":0,"content":"Pfizer \"UltraBOOST\" <u>shot</u>!","text":"Pfizer \"UltraBOOST\" <u>shot</u>!","html":"Pfizer \"UltraBOOST\" <u>shot</u>!"}],"langContent":"CN"},{"id":691956125,"gmtCreate":1640129869666,"gmtModify":1640129869762,"author":{"id":"3569730362364110","authorId":"3569730362364110","name":"CSK88","avatar":"https://static.tigerbbs.com/831855576c5b2d28ba9be7798d3c575e","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3569730362364110","idStr":"3569730362364110"},"htmlText":"Good to hear","listText":"Good to hear","text":"Good to hear","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691956125","repostId":1113826245,"repostType":4,"repost":{"id":"1113826245","kind":"news","pubTimestamp":1640127256,"share":"https://www.laohu8.com/m/news/1113826245?lang=&edition=full","pubTime":"2021-12-22 06:54","market":"us","language":"en","title":"FDA Expected to Authorize Pfizer and Merck Covid Pills This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1113826245","media":"Bloomberg","summary":"Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medi","content":"<ul>\n <li>Two drugs would be first at-home treatments for Covid-19</li>\n <li>U.S. has ordered 13 million courses of medicines so far</li>\n</ul>\n<p>The U.S. Food and Drug Administration is poised to authorize a pair of pills from&nbsp;Pfizer Inc.&nbsp;and&nbsp;Merck &amp; Co.&nbsp;to treat Covid-19 as soon as this week, according to people familiar with the matter -- a milestone in the fight against the pandemic that will soon expand therapies for the ill.</p>\n<p>An announcement may come as early as Wednesday, according to three of the people. They asked not to be identified ahead of the authorization and cautioned that the plan could change.</p>\n<p>Pfizer’s pill, Paxlovid, and Merck’s molnupiravir are intended for higher-risk people who test positive for the coronavirus. The treatments, in which patients take a series of pills at home over several days, could ease the burden on stretched hospitals with infections poised to soar through the winter in the U.S.</p>\n<p>The FDA declined to comment.</p>\n<p>“It’s the biggest thing to happen in the pandemic after vaccines,” said Eric Topol, director of the Scripps Research Translational Institute. The timing of the announcement, so late in the year, is unusual for the FDA and reflects the urgency behind the medicines, he added.</p>\n<p>The FDA authorizations may come with limitations on who should get which drugs., one of the people familiar with the matter said. A Food and Drug Administration advisory committee narrowly recommended the Merck pill last month, with some members of the panel citing safety concerns including for pregnant women.</p>\n<p>Pfizer closed at $58.95 a share in New York, down about 3.4%, while Merck closed at $75.54, down about 1.1%.</p>\n<p>White House Press Secretary Jen Psaki said she wouldn’t get ahead of any FDA decision.</p>\n<p>“But certainly, having antivirals available is another component that will help us fight the virus, address the pandemic, help people return to a version of normal and we will be prepared like Boy Scouts and Girl Scouts to ensure we are making these antivirals available to the public,” she said Tuesday.</p>\n<p>President Joe Biden, speaking at the White House on Tuesday about the omicron variant, said the current spike in cases is not like previous surges because of the availability of medical supplies and vaccines. He warned of increasing breakthrough cases in vaccinated people but assured Americans that almost of all of them would be mild or entirely asymptomatic.</p>\n<p>“No, this is not March of 2020,” he said.</p>\n<p>The U.S. government has ordered 10 million courses of the Pfizer pill and about 3 million courses of Merck’s, which isn’t as effective, clinical studies indicate, and may carry risks. However, the pills are likely to not be immediately available in widespread supply.</p>\n<p>In a clinical trial, Pfizer’s pill showed an 89% reduction in hospitalization for patients who received the medicine within three days of developing symptoms, compared to patients who got a placebo. None of the patients treated with the drug died.</p>\n<p>Authorization for Pfizer’s pill would represent a vote of confidence in the medicine from regulators, as FDA advisers have not been asked to consider the drug’s clinical evidence.</p>\n<p>Merck developed molnupiravir with partner&nbsp;Ridgeback Biotherapeutics LP.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Expected to Authorize Pfizer and Merck Covid Pills This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Expected to Authorize Pfizer and Merck Covid Pills This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 06:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medicines so far\n\nThe U.S. Food and Drug Administration is poised to authorize a pair of pills from ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113826245","content_text":"Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medicines so far\n\nThe U.S. Food and Drug Administration is poised to authorize a pair of pills from Pfizer Inc. and Merck & Co. to treat Covid-19 as soon as this week, according to people familiar with the matter -- a milestone in the fight against the pandemic that will soon expand therapies for the ill.\nAn announcement may come as early as Wednesday, according to three of the people. They asked not to be identified ahead of the authorization and cautioned that the plan could change.\nPfizer’s pill, Paxlovid, and Merck’s molnupiravir are intended for higher-risk people who test positive for the coronavirus. The treatments, in which patients take a series of pills at home over several days, could ease the burden on stretched hospitals with infections poised to soar through the winter in the U.S.\nThe FDA declined to comment.\n“It’s the biggest thing to happen in the pandemic after vaccines,” said Eric Topol, director of the Scripps Research Translational Institute. The timing of the announcement, so late in the year, is unusual for the FDA and reflects the urgency behind the medicines, he added.\nThe FDA authorizations may come with limitations on who should get which drugs., one of the people familiar with the matter said. A Food and Drug Administration advisory committee narrowly recommended the Merck pill last month, with some members of the panel citing safety concerns including for pregnant women.\nPfizer closed at $58.95 a share in New York, down about 3.4%, while Merck closed at $75.54, down about 1.1%.\nWhite House Press Secretary Jen Psaki said she wouldn’t get ahead of any FDA decision.\n“But certainly, having antivirals available is another component that will help us fight the virus, address the pandemic, help people return to a version of normal and we will be prepared like Boy Scouts and Girl Scouts to ensure we are making these antivirals available to the public,” she said Tuesday.\nPresident Joe Biden, speaking at the White House on Tuesday about the omicron variant, said the current spike in cases is not like previous surges because of the availability of medical supplies and vaccines. He warned of increasing breakthrough cases in vaccinated people but assured Americans that almost of all of them would be mild or entirely asymptomatic.\n“No, this is not March of 2020,” he said.\nThe U.S. government has ordered 10 million courses of the Pfizer pill and about 3 million courses of Merck’s, which isn’t as effective, clinical studies indicate, and may carry risks. However, the pills are likely to not be immediately available in widespread supply.\nIn a clinical trial, Pfizer’s pill showed an 89% reduction in hospitalization for patients who received the medicine within three days of developing symptoms, compared to patients who got a placebo. None of the patients treated with the drug died.\nAuthorization for Pfizer’s pill would represent a vote of confidence in the medicine from regulators, as FDA advisers have not been asked to consider the drug’s clinical evidence.\nMerck developed molnupiravir with partner Ridgeback Biotherapeutics LP.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691925495,"gmtCreate":1640129191844,"gmtModify":1640129192233,"author":{"id":"3578047933589423","authorId":"3578047933589423","name":"PengsieX","avatar":"https://static.tigerbbs.com/ebe92821eba3b91a6431d698b66bbed5","vip":1,"hat":"https://static.tigerbbs.com/f84859c65fc2d7681e28f6b8e9b0535a","crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3578047933589423","idStr":"3578047933589423"},"htmlText":"Jabs, pills... What's next","listText":"Jabs, pills... What's next","text":"Jabs, pills... What's next","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691925495","repostId":1113826245,"repostType":4,"repost":{"id":"1113826245","kind":"news","pubTimestamp":1640127256,"share":"https://www.laohu8.com/m/news/1113826245?lang=&edition=full","pubTime":"2021-12-22 06:54","market":"us","language":"en","title":"FDA Expected to Authorize Pfizer and Merck Covid Pills This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1113826245","media":"Bloomberg","summary":"Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medi","content":"<ul>\n <li>Two drugs would be first at-home treatments for Covid-19</li>\n <li>U.S. has ordered 13 million courses of medicines so far</li>\n</ul>\n<p>The U.S. Food and Drug Administration is poised to authorize a pair of pills from&nbsp;Pfizer Inc.&nbsp;and&nbsp;Merck &amp; Co.&nbsp;to treat Covid-19 as soon as this week, according to people familiar with the matter -- a milestone in the fight against the pandemic that will soon expand therapies for the ill.</p>\n<p>An announcement may come as early as Wednesday, according to three of the people. They asked not to be identified ahead of the authorization and cautioned that the plan could change.</p>\n<p>Pfizer’s pill, Paxlovid, and Merck’s molnupiravir are intended for higher-risk people who test positive for the coronavirus. The treatments, in which patients take a series of pills at home over several days, could ease the burden on stretched hospitals with infections poised to soar through the winter in the U.S.</p>\n<p>The FDA declined to comment.</p>\n<p>“It’s the biggest thing to happen in the pandemic after vaccines,” said Eric Topol, director of the Scripps Research Translational Institute. The timing of the announcement, so late in the year, is unusual for the FDA and reflects the urgency behind the medicines, he added.</p>\n<p>The FDA authorizations may come with limitations on who should get which drugs., one of the people familiar with the matter said. A Food and Drug Administration advisory committee narrowly recommended the Merck pill last month, with some members of the panel citing safety concerns including for pregnant women.</p>\n<p>Pfizer closed at $58.95 a share in New York, down about 3.4%, while Merck closed at $75.54, down about 1.1%.</p>\n<p>White House Press Secretary Jen Psaki said she wouldn’t get ahead of any FDA decision.</p>\n<p>“But certainly, having antivirals available is another component that will help us fight the virus, address the pandemic, help people return to a version of normal and we will be prepared like Boy Scouts and Girl Scouts to ensure we are making these antivirals available to the public,” she said Tuesday.</p>\n<p>President Joe Biden, speaking at the White House on Tuesday about the omicron variant, said the current spike in cases is not like previous surges because of the availability of medical supplies and vaccines. He warned of increasing breakthrough cases in vaccinated people but assured Americans that almost of all of them would be mild or entirely asymptomatic.</p>\n<p>“No, this is not March of 2020,” he said.</p>\n<p>The U.S. government has ordered 10 million courses of the Pfizer pill and about 3 million courses of Merck’s, which isn’t as effective, clinical studies indicate, and may carry risks. However, the pills are likely to not be immediately available in widespread supply.</p>\n<p>In a clinical trial, Pfizer’s pill showed an 89% reduction in hospitalization for patients who received the medicine within three days of developing symptoms, compared to patients who got a placebo. None of the patients treated with the drug died.</p>\n<p>Authorization for Pfizer’s pill would represent a vote of confidence in the medicine from regulators, as FDA advisers have not been asked to consider the drug’s clinical evidence.</p>\n<p>Merck developed molnupiravir with partner&nbsp;Ridgeback Biotherapeutics LP.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Expected to Authorize Pfizer and Merck Covid Pills This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Expected to Authorize Pfizer and Merck Covid Pills This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 06:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medicines so far\n\nThe U.S. Food and Drug Administration is poised to authorize a pair of pills from ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-21/fda-expected-to-authorize-pfizer-merck-covid-pills-this-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113826245","content_text":"Two drugs would be first at-home treatments for Covid-19\nU.S. has ordered 13 million courses of medicines so far\n\nThe U.S. Food and Drug Administration is poised to authorize a pair of pills from Pfizer Inc. and Merck & Co. to treat Covid-19 as soon as this week, according to people familiar with the matter -- a milestone in the fight against the pandemic that will soon expand therapies for the ill.\nAn announcement may come as early as Wednesday, according to three of the people. They asked not to be identified ahead of the authorization and cautioned that the plan could change.\nPfizer’s pill, Paxlovid, and Merck’s molnupiravir are intended for higher-risk people who test positive for the coronavirus. The treatments, in which patients take a series of pills at home over several days, could ease the burden on stretched hospitals with infections poised to soar through the winter in the U.S.\nThe FDA declined to comment.\n“It’s the biggest thing to happen in the pandemic after vaccines,” said Eric Topol, director of the Scripps Research Translational Institute. The timing of the announcement, so late in the year, is unusual for the FDA and reflects the urgency behind the medicines, he added.\nThe FDA authorizations may come with limitations on who should get which drugs., one of the people familiar with the matter said. A Food and Drug Administration advisory committee narrowly recommended the Merck pill last month, with some members of the panel citing safety concerns including for pregnant women.\nPfizer closed at $58.95 a share in New York, down about 3.4%, while Merck closed at $75.54, down about 1.1%.\nWhite House Press Secretary Jen Psaki said she wouldn’t get ahead of any FDA decision.\n“But certainly, having antivirals available is another component that will help us fight the virus, address the pandemic, help people return to a version of normal and we will be prepared like Boy Scouts and Girl Scouts to ensure we are making these antivirals available to the public,” she said Tuesday.\nPresident Joe Biden, speaking at the White House on Tuesday about the omicron variant, said the current spike in cases is not like previous surges because of the availability of medical supplies and vaccines. He warned of increasing breakthrough cases in vaccinated people but assured Americans that almost of all of them would be mild or entirely asymptomatic.\n“No, this is not March of 2020,” he said.\nThe U.S. government has ordered 10 million courses of the Pfizer pill and about 3 million courses of Merck’s, which isn’t as effective, clinical studies indicate, and may carry risks. However, the pills are likely to not be immediately available in widespread supply.\nIn a clinical trial, Pfizer’s pill showed an 89% reduction in hospitalization for patients who received the medicine within three days of developing symptoms, compared to patients who got a placebo. None of the patients treated with the drug died.\nAuthorization for Pfizer’s pill would represent a vote of confidence in the medicine from regulators, as FDA advisers have not been asked to consider the drug’s clinical evidence.\nMerck developed molnupiravir with partner Ridgeback Biotherapeutics LP.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":49,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113826245"}